Squarepoint
AURA icon

Squarepoint’s Aura Biosciences AURA Stock Holding History

Squarepoint’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$605K Buy
+96,342
New +$689K ﹤0.01% 3232
2024
Q2 		– Sell
-10,447
Closed -$82K – 4041
2024
Q1 		$82K Buy
+10,447
New +$86.6K ﹤0.01% 3825

Other funds holding AURA

Medicxi Ventures Management
Medicxi Ventures Management St. Helier, Jersey $127M AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Levin Capital Strategies
Levin Capital Strategies New York $1.42B AUM 19.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Regency Capital Management
Regency Capital Management Honolulu, Hawaii $247M AUM 24.61% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
TBH Global Asset Management
TBH Global Asset Management Brentwood, Tennessee $571M AUM 20.57% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Squarepoint's AURA Position: Q3 2026 in Review

Squarepoint opened a new position in Aura Biosciences (AURA) in Q3 2026: 96,342 shares worth $605K. The stake represents ﹤0.01% of the portfolio and ranks #3232 among its holdings. This is a return to the name: Squarepoint previously reported a position in AURA as recently as Q1 2024.

Squarepoint first reported a position in AURA in Q1 2024 and has held it in 2 quarters since. 53 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

  • Squarepoint held 96,342 shares of Aura Biosciences worth $605K as of Q3 2026.
  • Aura Biosciences was a new Squarepoint position in Q3 2026.
  • Aura Biosciences made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3232 holding.
  • Squarepoint first reported a position in Aura Biosciences in Q1 2024 and has held it in 2 quarters since.
  • 53 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.